ATP-sensitive potassium channel activation mimics the protective effect of ischaemic preconditioning in the rat isolated working heart after prolonged hypothermic storage

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 1, 1999, Pages 20-25

  Hicks, Mark ^a   Du, Zu Y ^a   Jansz, Paul ^a   Rainer, Steven ^a   Spratt, Phillip ^a   Macdonald, Peter S ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

ATP sensitive potassium channels; Glibenclamide; Heart transplantation; Ischaemic preconditioning; Myocardial reperfusion injury; Organ preservation; Pinacidil

Indexed keywords

GLIBENCLAMIDE; PINACIDIL; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; ARTICLE; HEART BEAT; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART OUTPUT; HEART PROTECTION; HEMODYNAMICS; ISOLATED HEART; NONHUMAN; RAT; WATER CONTENT;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIOPLEGIC SOLUTIONS; GLYBURIDE; HEART RATE; HEMODYNAMIC PROCESSES; HYPOGLYCEMIC AGENTS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PINACIDIL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; VASODILATOR AGENTS; WATER;

EID: 0032891465     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.02985.x     Document Type: Article

References (39)

1. 1. Wheeldon D, Sharples L, Wallwork J, English T. Donor heart preservation survey. J. Heart Lung Transplant. 1992; 11: 986-93.
2. 2. Southard JH, Belzer FO. Organ preservation. Annu. Rev. Med. 1995; 46: 235-47.
3. 3. Richens D, Junius F, Hill A et al. Clinical study of crystalloid cardioplegia vs aspartate-enriched cardioplegia plus warm reperfusion for donor heart preservation. Transplant. Proc. 1993; 25: 1608-10.
4. 4. Walker DM, Yellon DM. Ischaemic preconditioning: From mechanisms to exploitation. Cardiovasc. Res. 1992; 26: 734-9.
5. 5. Lawson CS, Downey JM. Preconditioning: State of the art myocardial protection. Cardiovasc. Res. 1993; 27: 542-50.
6. 6. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrmann HC, Laskey WK. Adaption to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic and metabolic features. Circulation 1990; 82: 2044-51.
7. 7. Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu. Rev. Physiol. 1995; 57: 311-32.
8. 8. Cleveland JC, Meldrum DR, Rowland RT, Banerjee A, Harken AH. Optimal myocardial preservation: Cooling, cardioplegia and conditioning. Ann. Thorac. Surg. 1996; 61: 760-8.
9. ATP channels meet the requirements? Basic Res. Cardiol. 1996; 91: 31-4.
10. 10. Hearse DJ. Activation of ATP-sensitive potassium channels: A novel pharmacological approach to myocardial protection? Cardiovasc. Res. 1995; 30: 1-17.
11. ATP) openers to cardiac membranes: Correlation of binding affinities with cardioprotective and smooth muscle relaxing potencies. J. Med. Chem. 1998; 41: 271-5.
12. 12. Menasche P, Kevelaitis E, Mouas C, Grousset C, Piwnica A, Bloch G. Preconditioning with potassium channel openers. A new concept for enhancing cardioplegic protection? J. Thorac. Cardiovasc. Surg. 1995; 110: 1606-13.
13. 13. Menasche P, Mouas C, Grousset C. Is potassium channel opening an effective form of preconditioning before cardioplegia? Ann. Thorac. Surg. 1996; 61: 1764-8.
14. 14. Carr CS, Yellon DM. A highly selective ATP-dependent potassium channel opener mimics ischaemic preconditioning protection in isolated human atrium. Med. Sci. Res. 1996; 24: 651-4.
15. 15. Du ZY, Hicks M, Winlaw D, Spratt P, Macdonald P. Ischemic preconditioning enhances donor lung preservation in the rat. J. Heart Lung Transplant. 1996; 15: 1258-67.
16. 16. Karck M, Rahmanian P, Haverich A. Ischemic preconditioning enhances donor heart preservation. Transplantation 1996; 62: 17-22.
17. 17. Du ZY, Hicks M, Spratt P, Macdonald P. Enhanced preservation of the rat heart after prolonged hypothermic storage with the 21-aminosteroid compound U74500A. Asia Pacific Heart J. 1997; 6: 184-9.
18. 18. Du ZY, Hicks M, Spratt P, Mundy JA, Macdonald PS. Cardioprotective effects of pinacidil pretreatment and lazaroid (U74500A) preservation in isolated rat hearts after 12 hours hypothermic storage. Transplantation 1998; 66: 158-63.
19. 19. Choong YS, Gavin JB. Functional, metabolic and ultrastructural evidence for improved myocardial protection during severe ischaemic stress with MBS, a new crystalloid cardioplegic solution. J. Cardiovasc. Surg. 1996; 37: 275-84.
20. 20. Ishida T, Yarimizu K, Gute DC, Korthuis RJ. Mechanisms of ischemic preconditioning. Shock 1997; 8: 86-94.
21. 1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-6.
22. 22. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol. 1994; 266: H1145-52.
23. 23. Ping P, Zhang J, Qiu Y et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res. 1997; 81: 404-14.
24. + currents by protein kinase C and adenosine. Implications for ischemic preconditioning. Circ. Res. 1996; 78: 443-54.
25. + current in human and rabbit ventricular myocytes. Circ. Res. 1996; 78: 492-8.
26. 26. Yellon DM, Baxter GF. A 'second window of protection' or delayed preconditioning phenomenon: Future horizons for myocardial protection? J. Mol. Cell. Cardiol. 1995; 27: 1023-34.
27. 27. Kolocassides KG, Galinanes M, Hearse DJ. Ischemic preconditioning, cardioplegia or both? Differing approaches to myocardial and vascular protection. J. Mol. Cell. Cardiol. 1996; 28: 623-34.
28. 28. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion. Cardiovasc. Res. 1996; 32: 743-51.
29. 29. Hotter G, Closa D, Prados M et al. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem. Biophys. Res. Commun. 1996; 222: 27-32.
30. + channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ. Res. 1993; 73: 1193-201.
31. 31. Haeusler G, Lues I. Therapeutic potential of potassium channel activators in coronary heart disease. Eur. Heart J. 1994; 15 (Suppl. C): 82-8.
32. + channel activity in intact and permeabilized rat ventricular myocytes. J. Physiol. 1990; 234: 91-110.
33. ATP) openers in models of myocardial ischemia and reperfusion. Can. J. Physiol. Pharmacol. 1997; 75: 309-15.
34. ATP channel as a receptor for potassium channel openers. J. Biol. Chem. 1996; 271: 8796-9.
35. 35. Alkhulaifi AM, Yellon DM, Pugsley WB. Preconditioning the human heart during aorto-coronary bypass surgery. Eur. J. Cardiothorac. Surg. 1994; 8: 270-5.
36. 36. Perrault LP, Menasche P, Bel A et al. Ischemic preconditioning in cardiac surgery: A word of caution. J. Thorac. Cardiovasc. Surg. 1996; 112: 1378-86.
37. 37. Kaukoranta PK, Lepojarvi MPK, Ylitalo KV, Kiviluoma KT, Peuhkurinen KJ. Normothermic retrograde blood cardioplegia with or without preceding ischemic preconditioning. Ann. Thorac. Surg. 1997; 63: 1268-74.
38. 38. Burns PG, Krukenkamp IB, Caldarone CA, Kirvaitis RJ, Gaudette GR, Levitsky S. Is the preconditioning response conserved in senescent myocardium? Ann. Thorac. Surg. 1996; 61: 925-9.
39. 39. Menasche P. New strategies in myocardial preservation. Curr. Opin. Cardiol. 1997; 12: 504-14.